CATEGORY 1 CME
Premiere Date: March 20, 2025
Expiration Date: September 20, 2026
This exercise gives CE credit for:
1. Physicians (CME)
2. Different
All different clinicians both will obtain a CME Attendance Certificates or might select any of the kinds of CE credit score being supplied.
ACTIVITY GOAL
To current an introductory assessment of the neuropsychiatric signs of long-COVID or post-acute sequelae of COVID-19 (PASC) and describe a framework intervention strategy.
LEARNING OBJECTIVES
1. Establish the widespread neuropsychiatric sequelae of post-acute sequelae of COVID-19 (PASC) and perceive the underlying neurobiological mechanisms.
2. Talk about the evidence-based therapies and interventions for PASC’s neuropsychiatric signs.
TARGET AUDIENCE
This accredited persevering with training (CE) exercise is meant for psychiatrists, psychologists, main care physicians, doctor assistants, nurse practitioners, and different well being care professionals who search to enhance their look after sufferers with psychological well being issues related to PASC.
ACCREDITATION/CREDIT DESIGNATION/FINANCIAL SUPPORT
This exercise has been deliberate and carried out in accordance with the accreditation necessities and insurance policies of the Accreditation Council for Persevering with Medical Schooling (ACCME) by way of the joint providership of Physicians’ Schooling Useful resource®, LLC and Psychiatric Instances®. Physicians’ Schooling Useful resource, LLC is accredited by the ACCME to offer persevering with medical training for physicians.
Physicians’ Schooling Useful resource, LLC designates this enduring materials for a most of 1.5 AMA PRA Class 1 Credit™. Physicians ought to declare solely the credit score commensurate with the extent of their participation within the exercise.
This exercise is funded totally by Physicians’ Schooling Useful resource, LLC. No industrial help was acquired.
OFF-LABEL DISCLOSURE/DISCLAIMER
This accredited CE exercise might or might not focus on investigational, unapproved, or off-label use of medicine. Contributors are suggested to seek the advice of prescribing data for any merchandise mentioned. The data offered on this accredited CE exercise is for persevering with medical training functions solely and isn’t meant to substitute for the unbiased scientific judgment of a doctor relative to diagnostic or therapy choices for a particular affected person’s medical situation. The opinions expressed within the content material are solely these of the person college members and don’t mirror these of Physicians’ Schooling Useful resource, LLC.
FACULTY, STAFF, AND PLANNERS’ DISCLOSURES AND CONFLICT OF INTEREST MITIGATION
Not one of the workers of Physicians’ Schooling Useful resource, LLC or Psychiatric Instances or the planners or the authors of this academic exercise have related monetary relationship(s) to reveal with ineligible firms whose main enterprise is producing, advertising and marketing, promoting, reselling, or distributing well being care merchandise utilized by or on sufferers. All coauthors report no conflicts of curiosity.
Acknowledgment: This exercise is partially supported by the NIH grant AT009198-06 to Dr Lavretsky.
For content-related questions, e-mail us at PTEditor@mmhgroup.com; for questions in regards to the accreditation of this CME exercise or declare credit score, please contact data@gotoper.com and embody “Publish-Acute Sequelae of COVID-19 An infection Presenting With Neuropsychiatric Signs: Prognosis and Administration” within the topic line.
HOW TO CLAIM CREDIT
Upon getting learn the article, please use the next URL to guage and request credit score: https://training.gotoper.com/exercise/ptcme25mar. If you don’t have already got an account with PER®, you’ll be prompted to create one. You will need to have an account to guage and request credit score for this exercise.
Acute COVID-19 an infection is related to vital morbidity and mortality.1 In keeping with the weekly World Well being Group (WHO) report, as of September 1, 2024, roughly 776 million confirmed instances of SARS-CoV-2 have been reported for the reason that begin of the COVID-19 pandemic.2 Since then, proof has been rising to help the prevalence of long-term issues of COVID-19 (or lengthy COVID, additionally known as long-hauler syndrome, post-acute sequalae of COVID-19 [PASC], post-acute COVID sequelae [PACS]) past the acute part of the an infection. The heterogeneity within the array of issues of COVID-19 has led to numerous definitions for the syndrome. The Facilities for Illness Management and Prevention defines long-COVID as “indicators, signs, and situations that proceed or develop after preliminary COVID-19 or SARS-CoV-2 an infection. These indicators, signs, and situations are current 4 weeks or extra after the preliminary an infection.”3 In the meantime, the WHO developed a case definition of the post-COVID-19 situation because the “continuation or growth of recent signs 3 months after the preliminary SARS-CoV-2 an infection, with these signs lasting for at the least 2 months with no different clarification.”4 The Nationwide Institute for Well being and Care Excellence pointers determine publish–COVID-19 syndrome as “indicators and signs that develop throughout or after an an infection in step with COVID-19, proceed for greater than 12 weeks (3 months) and aren’t defined by another prognosis.”5 On this assessment, we are going to discuss with long-term issues of COVID-19 which can be current 12 weeks past the time of the acute an infection as PASC.
The WHO estimates that the share of people who’ve PASC at 10% to twenty%, although estimates differ.6 A number of research have reported on the range of PASC, recognizing it as a multiorgan illness with a broad spectrum of long-term manifestations, together with neuropsychiatric signs (see Desk 1).1,7-9 In about 50% of sufferers, signs can final for at the least 12 months or for a few years with excessive quality-of-life burden as evidenced by a major proportion of people who’re unable to return to work.9,10
TABLE 1. Neuropsychiatric Signs and Their Weighted Prevalence1,7-9
There are a number of, probably associated, mechanisms for the pathogenesis of PASC.9 Hypotheses embody immune dysregulation, microbiota dysbiosis, autoimmunity and immune priming, coagulopathies with blood clotting and endothelial abnormalities, and dysfunctional neurological signaling.9 The best high quality of proof helps the immune dysfunction speculation. A number of research have demonstrated that COVID-19 an infection can lead to immunologic perturbations that reach past acute an infection.11 Particularly, elevations of interleukin (IL)-6 and tumor necrosis issue (TNF)-α throughout early COVID-19 restoration on the 1 to 2 month timepoint have been related to the presence of PASC signs at 4 months; and elevations in ranges of IL-6, TNF-α, and IL-1B have been persistently reported in PASC.11 There’s additionally some proof to recommend that mind damage might underpin this pathology and significantly the neuropsychiatric signs of PASC, as knowledge from a UK-based examine that included pre- and post-COVID mind imaging confirmed an total discount in mind dimension with particular reductions in mind quantity within the parahippocampal gyrus, anterior cingulate cortex, temporal pole, orbitofrontal cortex, insula and supramarginal gyrus,12 thus suggesting accelerated inflamm-aging and mind growing old.
PASC Rating
The RECOVER initiative offered a scientific framework for figuring out and diagnosing PASC.13 This examine examined ongoing, relapsing, new signs or situations current 30 or extra days after COVID-19 an infection.13 Based mostly on their pattern, the examine recognized 37 signs with larger than 2.5% frequency, then additional chosen the 12 signs with the best log-odds ratio.13 These signs have been then assigned corresponding scores starting from 1 to eight (Desk 2).13 Contributors are deemed PASC constructive if they’ve a complete rating larger than or equal to 12.13 Growing ranges of PASC scores have been related to progressively worse measures of well-being and functioning.13 In scientific observe, PASC scores could also be used to systematically diagnose sufferers with PASC. Though simply 12 signs contributed to the PASC rating, different signs stay vital, contemplating their potential opposed impression on health-related high quality of life.
TABLE 2. Signs That Outline PASC and Their Corresponding Scores12
Scientific Case
“Ms Okay” is a 56-year-old lady with a medical historical past vital for hypertension and hypothyroidism on levothyroxine and a psychiatric historical past of recurrent main depressive dysfunction who presents to the multidisciplinary PASC clinic for a psychiatric evaluation on the suggestion of her main care doctor. Ms Okay has a historical past of two depressive episodes and is at the moment maintained on citalopram 20 mg as soon as day by day, which has been efficient in reaching remission of her signs. Ms Okay studies contracting COVID-19 for the primary time about 6 months in the past, and since then she has been experiencing low vitality, fatigue, and poor focus and reminiscence. She has additionally been experiencing persistent depressed temper, anhedonia, and poor sleep. She will full family chores however must relaxation for a major period of time with postexertional fatigue. Moreover, she has been having difficulties finishing her duties at work on account of inattention and protracted mind fog. She denies anosmia however endorses low urge for food since her an infection, nonetheless. She additionally has skilled complications and a cough since her preliminary an infection. She denies vital anxiousness. Psychometric scales are accomplished and are as follows: PHQ-9 = 22; GAD-7 = 6; Columbia-Suicide Severity Ranking Scale (C-SSRS) is adverse. Her PASC rating is 15 (constructive for postexertional malaise, continual cough, occasional complications, mind fog with poor reminiscence and focus, and fatigue).
An entire blood depend, complete metabolic panel, thyroid-stimulating hormone, vitamin B12, vitamin D, hemoglobin A1c, and antinuclear antibody check have been ordered and have been within the regular vary. MRI of mind was adverse for any acute stroke or mass impact however confirmed minimal microvascular illness current within the deep white matter. She was referred for neuropsychological testing, which exhibited some impairment of consideration and dealing reminiscence that recommended decline from the prior stage of functioning.
She was began on augmentation remedy with bupropion XL 150 mg that was elevated to 300 mg after 4 weeks. She was additionally began on naltrexone 1.5 mg day by day that was up-titrated to a closing dose of 4.5 mg over the course of 8 weeks. Ultimately, because of the lack of great enchancment in cognitive functioning, she was began on memantine 5 mg as much as 20 mg and was requested to take vitamin B advanced, fish oil containing ω-3 fatty acid dietary supplements, and magnesium to assist her cognition and temper. She additionally began melatonin 3 to five mg at evening for insomnia. Moreover, Ms Okay engaged in graded bodily exercise and mind-body workouts, together with yoga and tai chi. She additionally realized and used respiration workouts (eg, boxed respiration 3 seconds inhale, 3 seconds maintain, 3 seconds exhale, 3 seconds maintain, for 3 to five minutes for administration of her anxiousness and sleep). She adopted up with outpatient psychotherapy and engaged in acceptance and dedication remedy.
Over the subsequent 9 months, Ms Okay’s signs improved considerably. Her vitality and fatigue improved, and he or she has been happening longer walks along with her boyfriend. She not too long ago joined a qigong group within the senior heart close to her house. She is best in a position to handle chores and has been socializing with buddies. Moreover, her temper has improved, and he or she has been practising meditation through a meditation app that she downloaded on her telephone. Her focus and mind fog considerably improved, and he or she was in a position to return to work and full her duties appropriately.
Neuropsychiatric Signs
Neuropsychiatric signs related to PASC are numerous (see Desk 1)1,7-9 and are extra prevalent in nonhospitalized sufferers, suggesting a better incidence of neuropsychiatric signs in these with less-severe COVID-19 infections.1 Moreover, the prevalence of those signs seems to extend over time.1
Many people expertise continual fatigue signs after decision of an acute COVID-19 an infection, with a better proportion of ladies reporting fatigue signs in contrast with males.14 Round 75% of sufferers with continual fatigue syndrome in PASC are unable to work full time; of those, 25% have extreme signs and are depending on others for care.15 The pathophysiology of continual fatigue in PASC is regarded as just like that of syndromes following different acute viral infections. Particularly, PASC overlaps with myalgic encephalomyelitis/continual fatigue syndrome (ME/CFS). The 2015 Institute of Medication report classifies people as having ME/CFS-like sickness if 1 of the 4 standards are met: (1) discount in means to interact in pre-illness occupational, social, or private exercise ranges that lasts for greater than 6 months and is accompanied by profound fatigue not relieved by relaxation; (2) postexertional malaise; (3) unrefreshing sleep; and (4) cognitive impairment or orthostatic intolerance.16
The time period mind fog, whereas not a medical prognosis, is usually used to explain lingering cognitive difficulties seen in PASC.17 The cognitive deficits in sufferers with PASC are just like these discovered with 10 years of accelerated mind growing old,18 usually presenting as a dysexecutive syndrome that results in issues with planning, reasoning, and problem-solving. A number of research have investigated the potential danger elements of creating cognitive impairment and decline related to PASC. Asadi-Pooya et al discovered that signs of feminine sufferers being admitted to the intensive care unit have been considerably related to continual PASC mind fog.19
Despair, characterised by steady low temper and/or anhedonia together with neurovegetative signs lasting for greater than 2 weeks, is usually seen in sufferers with PASC. Depressive signs in these sufferers have been linked to poor neurocognitive perform, elevated fatigue, and sleep disturbances.17 Curiously, anhedonia outlined because the lack of curiosity or means to expertise pleasure is a predominant symptom of main depressive dysfunction and has been famous in scientific descriptions of PASC.20 Excessive ranges of anhedonia have been detected each within the acute post-COVID-19 an infection part20 and throughout the PASC part,21 in the end resulting in poorer high quality of life. A number of hypotheses point out that sustained neuroinflammatory processes disrupting the blood-brain barrier, leading to neural and glial cell atrophy together with morphological adjustments throughout the nucleus accumbens, might contribute to persistent anhedonia.22
Posttraumatic stress dysfunction (PTSD) is usually seen in sufferers with PASC.23,24 Being feminine has been recognized as a danger issue, with girls extra more likely to develop PTSD as a part of PASC.25 Outcomes of a examine by Houben-Wilke et al indicated that widespread PTSD signs present in sufferers 3 months after onset of COVID-19 signs included “upsetting ideas or recollections concerning the occasion, issue falling or staying asleep, and issue concentrating.”26 Sufferers with PTSD have been extra more likely to expertise persistent signs of shortness of breath, myalgias, confusion, anorexia, and have been much less more likely to return to work.27
Administration
Pharmacologic Interventions
At the moment, there aren’t any US Meals and Drug Administration–accredited pharmacologic therapies for PASC; nevertheless, there have been many ongoing research and trials on potential therapies.
Outcomes of a current retrospective population-based examine by Sidky et al confirmed that the usage of selective serotonin reuptake inhibitor (SSRI) drugs at baseline was related to a major (26%) discount within the danger of PASC.28 The examine posited that the sigma-1-receptor performs a job within the mechanism of motion of SARS-CoV-2 and SSRIs, which have potent sigma-1 receptor agonism, and SSRIs corresponding to fluoxetine, escitalopram, and fluvoxamine could also be a possible avenue to pursue as therapeutic or prophylactic medicine for PASC.28 Moreover, given the immune dysregulation speculation of PASC, there was curiosity in serotonergic brokers with anti-inflammatory exercise. Fenton et al recommended that SSRIs could also be efficient within the therapy of melancholy in sufferers with PASC.29 Different trials have studied vortioxetine as a possible therapy, given proof that it not directly targets immune-inflammatory effectors corresponding to peroxisome proliferator-activated receptor-γ, TNF-α, and cyclooxygenase-2.30 In a Canadian examine, vortioxetine was proven to enhance cognitive perform in people with PASC who had immune-inflammatory activation as evidenced by above-average baseline C-reactive protein ranges.30 The identical examine additionally confirmed that vortioxetine had antidepressant results and improved high quality of life in people with PASC.30
There’s additionally some proof for the usage of famotidine, a histamine H2 receptor antagonist that’s generally utilized in therapy of gastroesophageal reflux illness, for therapy of PASC.31 Outcomes of 1 case examine confirmed that famotidine had some efficacy in lowering COVID-19–induced neuropsychiatric signs with the affected person endorsing enchancment in signs of heightened emotional reactivity and diminished motivation.32 Additional scientific trials on famotidine have proven its efficacy for addressing cognitive impairment, melancholy, and anxiousness, with sufferers on famotidine having considerably greater Mini-Psychological State Examination scores and Montreal Cognitive Evaluation scores, in addition to vital enhancements in Hamilton Despair Ranking Scale and Hamilton Nervousness Ranking Scale scores.31 Different trials have thought of the efficacy of α2A-adrenoceptor agonists corresponding to guanfacine, in addition to N-acetylcysteine for the therapy of neuropsychiatric signs of PACS.33 Lastly, given the aforementioned dialogue of the overlaps of PASC with ME/CFS, many methods for ME/CFS could also be efficient for people with PASC.14 For instance, low-dose naltrexone and low-dose aripiprazole have been utilized in ME/CFS to deal with a variety of signs,14 although randomized managed trials for sufferers with PASC are ongoing or forthcoming.
Multidisciplinary Groups
Within the absence of accredited pharmacologic therapies for PASC, a balanced integrative strategy that mixes pharmacotherapy, psychotherapy, and complementary drugs might show helpful in addressing scientific signs. The cognitive, behavioral, and bodily sequelae of those signs require care throughout a number of subspecialties, together with main care, cardiology, pulmonology, neurology, rheumatology, infectious illness, and psychiatry to handle the big variety of PASC signs. This multidisciplinary strategy has been demonstrated by way of the creation of publish–COVID-19 clinics that provide diagnostic, therapy, and help providers and meet the wants of the rising inhabitants of survivors. This integration will even enable for identification of scientific patterns to include into ongoing analysis efforts to know the issues of PASC. There stay some challenges to this multidisciplinary strategy, which embody restricted assets, time, availability, funds, and geographic location as optimum therapy requires the involvement of a number of subspecialists who work collaboratively as a workforce.
Integrative Approaches
Complementary and integrative drugs (CAM) interventions are rising in recognition as doable therapies for PASC signs. A number of current meta-analyses have mentioned the usage of CAM modalities for the therapy of PASC.34,35 Broadly, interventions corresponding to transcutaneous auricular vagus nerve stimulation, olfactory coaching, dietary dietary supplements, neuro-meditation (Rebalance, which incorporates sound remedy and coach-guided meditation related to mild stimulations), chromotherapy, and aromatherapy might have efficacy in treating PASC signs.34 Hawkins et al demonstrated that aromatherapy considerably improved vitality ranges amongst girls experiencing PASC.36 In the meantime, supplementation with L-arginine plus vitamin C improved persistent fatigue in sufferers with PASC.37 Whereas at the least 8 separate randomized managed trials have evaluated the impact of various oral Chinese language natural drugs formulation on PASC-related continual fatigue, it’s unsure if these interventions characterize an efficacious therapy possibility given the restricted proof for many outcomes.35
In distinction, mind-body therapies (MBTs) have a stronger physique of proof to help their use within the therapy of psychiatric diseases (together with PTSD, anxiousness, melancholy, and neurocognitive issues) on account of their results on stress discount and promotion of psychological and bodily well-being and may very well be additional utilized to PASC.38,39 Moreover, MBTs may be carried out in routine scientific observe as they’re protected, minimally invasive, well-tolerated, and cost-effective. MBTs may be divided into mindfulness workouts and meditative practices. Conscious motion workouts that combine aware respiration practices with conscious motion embody yoga, tai chi, and qigong. Meditative practices that don’t embody motion are made up of progressive rest, mindfulness, meditation, and acceptance therapies. Mechanistically, MBTs have been proven to have an effect on immune perform, inflicting adjustments in markers of irritation, cell-mediated immunity, and organic growing old.40,41 A current paper examined the function of Sudarshan Kriya Yoga (SKY), a sophisticated managed cyclic rhythmic respiration method, in oxidative stress and immune response and posited a possible utility to sufferers with PASC.42 SKY might act as an vital therapeutic intervention to enhance PTSD and psychological stress related to anxiousness and anticipatory anxiousness associated to COVID-19 infections.42 One other current assessment explored the usage of qigong as an integrative help for PASC and located that throughout 9 research, outcomes confirmed that people collaborating in qigong had enhancements in each bodily and psychological well-being, as evidenced by enchancment in persistent respiratory points, dizziness, sleep disturbances, and health-related high quality of life.43 Concerning meditation, a current examine on neuro-meditation confirmed that 10 30-minute periods might considerably enhance cognitive performances in PASC, as evidenced by a major enchancment on a group of 5 computerized cognitive duties, in addition to vital decreases in subjective studies of bodily and psychological fatigue, muscle and joint ache, signs of melancholy and anxiousness, temper disturbances, and poor sleep high quality.44
Ongoing Scientific Trials
Greater than 400 scientific trials on PASC are ongoing per a assessment of clinicaltrials.gov in September 2024.45 Research span a variety of subjects from additional elucidating the mechanism of PASC pathology to figuring out danger elements for growth of PASC to novel therapeutic approaches. Interventions at the moment being studied embody pharmacologic interventions (with metformin, naltrexone, fluvoxamine, lithium, amphetamine-dextroamphetamine, amantadine, modafinil, and vortioxetine), neuromodulation, integrative approaches (with Chinese language conventional natural drugs, sauna/hyperthermia), mind-body interventions (with yoga and qigong), and psychotherapy (mindfulness-based stress discount and cognitive behavioral remedy).45 The way forward for PASC therapy will proceed to evolve as additional research are printed on evidence-based therapy modalities.
Concluding Ideas
Survivors of the acute COVID-19 an infection are at an elevated danger of neuropsychiatric sequelae that may result in vital morbidity, cognitive decline, accelerated growing old, and elevated incapacity and mortality. The severity, timeframe, and therapy of every sequela are troublesome to guage. PASC scores can be utilized to diagnose long-COVID. Whereas at the moment there aren’t any validated therapies for PASC, many research present promising outcomes for potential therapies. An integrative strategy that features pharmacotherapy, MBTs, dietary supplements, and psychotherapy could also be essential to offer aid of PASC neuropsychiatric signs. The long run stays shiny, with many ongoing scientific trials on therapy modalities together with pharmacologic interventions, neuromodulation, integrative approaches, mind-body interventions, and psychotherapy.
Dr Meghan Reddy is a psychiatry resident at College of California, Los Angeles (UCLA), Semel Institute for Neuroscience. Dr Kalyn Reddy is a resident at College of California Irvine, College of Medication. Dr Oughli is an assistant scientific professor within the Division of Psychiatry and Biobehavioral Sciences on the College of California, Los Angeles. Dr Nguyen is an assistant scientific professor within the Division of Psychiatry and Biobehavioral Sciences, David Geffen College of Medication, at UCLA. She can also be affiliate program director of the UCLA Psychiatry Residency Coaching Program and affiliate director of the UCLA Integrative Psychiatry Clinic. Dr Lavretsky is a professor in residence within the Division of Psychiatry at UCLA. She is president of the American Affiliation for Geriatric Psychiatry, a distinguished fellow of the American Psychiatric Affiliation and the American Affiliation for Geriatric Psychiatry, and a fellow of the American Faculty of Neuropsychopharmacology. She can also be on the Editorial Board of Psychiatric Instances.
References
1. Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.
2. WHO COVID-19 dashboard. WHO. Up to date January 5, 2025. Accessed January 22, 2025. https://knowledge.who.int/dashboards/covid19/instances
3. Lengthy COVID fundamentals. CDC. Up to date July 11, 2024. Accessed December 19, 2024. https://www.cdc.gov/covid/long-term-effects/index.html
4. Coronavirus illness 2019 (COVID-19): Scenario Report, 73. WHO. April 2, 2020. Accessed December 19, 2024. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf
5. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long run results of covid-19: abstract of NICE, SIGN, and RCGP fast guideline. BMJ. 2021;372:n136.
6. Publish COVID-19 situation (lengthy COVID). WHO. Up to date December 7, 2022. Accessed December 19, 2024. https://www.who.int/europe/news-room/fact-sheets/merchandise/post-covid-19-condition
7. Badenoch JB, Rengasamy ER, Watson C, et al. Persistent neuropsychiatric signs after COVID-19: a scientific assessment and meta-analysis. Mind Commun. 2021;4(1):fcab297.
8. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. Greater than 50 long-term results of COVID-19: a scientific assessment and meta-analysis. Sci Rep. 2021;11(16144).
9. Davis HE, McCorkell L, Vogel JM, Topol EJ. Lengthy COVID: main findings, mechanisms and proposals. Nat Rev Microbiol. 2023;21(3):133-146.
10. Takao M, Ohira M. Neurological post-acute sequelae of SARS-CoV-2 an infection. Psychiatry Clin Neurosci. 2023;77(2):72-83.
11. Bonilla H, Peluso MJ, Rodgers Okay, et al. Therapeutic trials for lengthy COVID-19: a name to motion from the interventions taskforce of the RECOVER initiative. Entrance Immunol. 2023;14:1129459.
12. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is related to adjustments in mind construction in UK Biobank. Nature. 2022;604(7907):697-707.
13. Thaweethai T, Jolley SE, Karlson EW, et al; RECOVER Consortium. Improvement of a definition of postacute sequelae of SARS-CoV-2 an infection. JAMA. 2023;329(22):1934-1946.
14. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a scientific assessment and meta-analysis. Mind Behav Immun. 2022;101:93-135.
15. Bateman L, Bested AC, Bonilla HF, et al. Myalgic encephalomyelitis/continual fatigue syndrome: necessities of prognosis and administration. Mayo Clin Proc. 2021;96(11):2861-2878.
16. Clayton EW. Past myalgic encephalomyelitis/continual fatigue syndrome: an IOM report on redefining an sickness. JAMA. 2015;313(11):1101-1102.
17. Mazza MG, Palladini M, Poletti S, Benedetti F. Publish-COVID-19 depressive signs: epidemiology, pathophysiology, and pharmacological therapy. CNS Medicine. 2022;36(7):681-702.
18. Holdsworth DA, Chamley R, Barker-Davies R, et al. Complete scientific evaluation identifies particular neurocognitive deficits in working-age sufferers with long-COVID. PLoS One. 2022;17(6):e0267392.
19. Asadi-Pooya AA, Akbari A, Emami A, et al. Lengthy COVID syndrome-associated mind fog. J Med Virol. 2022;94(3):979-984.
20. El Sayed S, Shokry D, Gomaa SM. Publish-COVID-19 fatigue and anhedonia: a cross-sectional examine and their correlation to post-recovery interval. Neuropsychopharmacol Rep. 2021;41(1):50-55.
21. Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Publish-acute sequelae of COVID-19: proof of temper & cognitive impairment. Mind Behav Immun Well being. 2021;17:100347.
22. Alonso-Lana S, Marquié M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and results on aged people with dementia. Entrance Ageing Neurosci. 2020;12:588872.
23. Taquet M, Dercon Q, Luciano S, et al. Incidence, co-occurrence, and evolution of long-COVID options: a 6-month retrospective cohort examine of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.
24. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort examine utilizing digital well being information. Lancet Psychiatry. 2021;8(5):416-427.
25. Bai F, Tomasoni D, Falcinella C, et al. Feminine gender is related to lengthy COVID syndrome: a potential cohort examine. Clin Microbiol Infect. 2022;28(4):611.e9-11.e16.
25. Houben-Wilke S, Goërtz YM, Delbressine JM, et al. The impression of lengthy COVID-19 on psychological well being: observational 6-month follow-up examine. JMIR Ment Well being. 2022;9(2):e33704.
27. Pilotto A, Padovani A; ENCOVID-BIO Community. Reply to the letter “COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation.” Ann Neurol. 2020;88(4):861-862.
28. Sidky H, Hansen KA, Girvin AT, et al; N3C consortium. Assessing the impact of selective serotonin reuptake inhibitors within the prevention of post-acute sequelae of COVID-19. Comput Struct Biotechnol J. 2024;24:115-125.
29. Fenton C, Lee A. Antidepressants with anti-inflammatory properties could also be helpful in lengthy COVID melancholy. Medicine Ther Perspect. 2023;39(2):65-70.
30. McIntyre RS, Phan L, Kwan ATH, et al. Vortioxetine for the therapy of post-COVID-19 situation: a randomized managed trial. Mind. 2024;147(3):849-857.
31. Momtazmanesh S, Ansari S, Izadi Z, et al. Impact of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 an infection: a randomized, double-blind, and placebo-controlled examine. J Psychosom Res. 2023;172:111389.
32. Alper Okay. Case report: famotidine for neuropsychiatric signs in COVID-19. Entrance Med (Lausanne). 2020;7:614393.
33. Fesharaki-Zadeh A, Lowe N, Arnsten AFT. Scientific expertise with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the therapy of cognitive deficits in “long-COVID19.” Neuroimmunology Stories. 2023;3:100154.
34. Yang J, Lim KH, Lim KT, et al. Complementary and various drugs for lengthy COVID: a scientific assessment of randomized managed trials. Ther Adv Power Dis. 2023;14:20406223231204727.
35. Chen XY, Lu CL, Wang QY, et al. Conventional, complementary and integrative drugs for fatigue publish COVID-19 an infection: a scientific assessment of randomized managed trials. Integr Med Res. 2024;13(2):101039.
36. Hawkins J, Hires C, Keenan L, Dunne E. Aromatherapy mix of thyme, orange, clove bud, and frankincense boosts vitality ranges in post-COVID-19 feminine sufferers: a randomized, double-blinded, placebo managed scientific trial. Complement Ther Med. 2022;67:102823.
37. Tosato M, Calvani R, Picca A, et al; Gemelli In opposition to COVID-19 Publish-Acute Care Group. Results of l-arginine plus vitamin C supplementation on bodily efficiency, endothelial perform, and protracted fatigue in adults with lengthy COVID: a single-blind randomized managed trial. Vitamins. 2022;14(23):4984.
38. Nguyen SA, Lavretsky H. Rising complementary and integrative therapies for geriatric psychological well being. Curr Deal with Choices Psychiatry. 2020;7(4):447-470.
39. Nguyen SA, Oughli HA, Lavretsky H. Complementary and integrative drugs for neurocognitive issues and caregiver well being. Curr Psychiatry Rep. 2022;24(9):469-480.
40. Mazza MG, De Lorenzo R, Conte C, et al; COVID-19 BioB Outpatient Clinic Research group. Nervousness and melancholy in COVID-19 survivors: function of inflammatory and scientific predictors. Mind Behav Immun. 2020;89:594-600.
41. Black DS, Slavich GM. Mindfulness meditation and the immune system: a scientific assessment of randomized managed trials. Ann N Y Acad Sci. 2016;1373(1):13-24.
42. Zope SA, Zope RA, Biri GA, Zope CS. Sudarshan Kriya yoga: a breath of hope throughout COVID-19 pandemic. Int J Yoga. 2021;14(1):18-25.
43. Antonelli M, Donelli D. Evaluating qigong as integrative help for COVID-19 and long-COVID-19 rehabilitation: a scientific assessment. Entrance Psychol. 2024;15:1403130.
44. Hausswirth C, Schmit C, Rougier Y, Coste A. Optimistic impacts of a four-week neuro-meditation program on cognitive perform in post-acute sequelae of COVID-19 sufferers: a randomized managed trial. Int J Environ Res Public Well being. 2023;20(2):1361.
45. Nationwide Library of Medication: Nationwide Middle for Biotechnology Info. Search outcomes for:Â lengthy COVID; different phrases: PASC Publish Acute Sequelae of COVID 19. Clinicaltrials.gov. September 18, 2024. Accessed December 19, 2024. https://clinicaltrials.gov/search?cond=Longpercent20COVID&time period=PASCpercent20Postpercent20Acutepercent20Sequelaepercent20ofpercent20COVIDpercent2019
